MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$339,380K
Net Income
$33,010K
Net Profit Margin
9.73%
EPS
$0.72
Unit: Thousand (K) dollars
Revenue Breakdown
Plasma Productsand Services
Blood Management Technologies Pr...
Interventional Technologies Prod...
Product And Service Other
Revenue Breakdown
US
Europe
Asia
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-27
2026-03-28
2025-12-27
2025-09-27
Net revenues
339,380
346,351
338,967
327,315
Cost of goods sold
136,577
148,139
136,581
132,571
Gross profit
202,803
198,212
202,386
194,744
Research and development
16,200
14,446
14,187
14,872
Selling, general and administrative
118,941
120,933
109,154
101,615
Amortization of acquired assets
10,204
10,491
10,933
11,182
Remeasurement of contingent consideration
-
-470*
-
-
Impairment of intangible assets
-
75,837*
716
8,584
Total operating expenses
145,345
221,237
134,990
136,253
Operating income
57,458
-23,025
67,396
58,491
Interest and other expense, net
-9,884
-5,374
-7,421
-7,206
Income before provision for income taxes
47,574
-28,399
59,975
51,285
Provision for income taxes
14,564
-8,252
15,235
12,601
Net income
33,010
-20,147
44,740
38,684
Basic EPS
0.73
-0.436
0.96
0.81
Diluted EPS
0.72
-0.434
0.95
0.81
Basic Average Shares
45,361,000
46,223,000
46,792,000
47,590,000
Diluted Average Shares
45,704,000
46,412,000
46,987,000
47,664,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Plasma Productsand
Services
$155,524K
Product And Service
Other
$35,794K
Blood Management
Technologies Product And...
$88,120K
Interventional Technologies
Product And Service
$59,942K
Apheresis
$191,318K
Med Surg
$148,062K
Net revenues
$339,380K
(5.60%↑ Y/Y)
Gross profit
$202,803K
(5.49%↑ Y/Y)
Cost of goods sold
$136,577K
(5.75%↑ Y/Y)
Operating income
$57,458K
(6.66%↑ Y/Y)
Total operating
expenses
$145,345K
(5.04%↑ Y/Y)
Income before
provision for income taxes
$47,574K
(5.32%↑ Y/Y)
Interest and other
expense, net
-$9,884K
(-13.57%↓ Y/Y)
Selling, general and
administrative
$118,941K
(7.43%↑ Y/Y)
Research and development
$16,200K
(-0.38%↓ Y/Y)
Amortization of acquired
assets
$10,204K
(-10.43%↓ Y/Y)
Net income
$33,010K
(-3.00%↓ Y/Y)
Provision for income taxes
$14,564K
(30.76%↑ Y/Y)
Buy us a coffee
HAEMONETICS CORP (HAE)
HAEMONETICS CORP (HAE)